Abstract | OBJECTIVE: METHODS: Thirty-four male Wistar rats were randomly divided into 3 groups: control group, which was fed a standard diet, DM group, high-fat diet and injected with streptozotocin, and Ang-(1-7) group receiving an injection of streptozotocin followed by Ang-(1-7) treatment. Blood glucose level, fasting serum Ang II and insulin levels, and homeostasis model assessment of insulin resistance (HOMA-IR) were measured. The pancreases were collected for histological examination, protein and gene expression analysis. RESULTS: Compared with the control group, fasting blood glucose, serum angiotensin II level, and HOMA-IR value increased, while serum insulin level decreased in the DM group. Moreover, islet structure was damaged, β cells were irregularly arranged, the cytoplasm was loose in the DM group. Expressions of Pancreatic duodenal homeobox-1 (Pdx1), glucose transporter-2 (Glut2) and glucokinase (Gk) were significantly decreased in the DM group compared with the control group. However, the DM-associated changes were dramatically reversed following Ang-(1-7) treatment. CONCLUSION: Ang-(1-7) protects against streptozotocin-induced DM through the improvement of insulin secretion, insulin resistance and islet fibrosis, which is associated with the upregulation of Pdx1, Glut2 and Gk expressions.
|
Authors | Jingjing Li, Ruifang Zhu, Yalin Liu, Jinhui Yang, Xiaoyan Wang, Lisha Geng, Tingting Xu, Junhua He |
Journal | Endocrine, metabolic & immune disorders drug targets
(Endocr Metab Immune Disord Drug Targets)
Vol. 21
Issue 1
Pg. 156-162
( 2021)
ISSN: 2212-3873 [Electronic] United Arab Emirates |
PMID | 32679026
(Publication Type: Journal Article)
|
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at [email protected]. |
Chemical References |
- Glucose Transporter Type 2
- Homeodomain Proteins
- Peptide Fragments
- Slc2a2 protein, rat
- Trans-Activators
- pancreatic and duodenal homeobox 1 protein
- Streptozocin
- Angiotensin I
- angiotensin I (1-7)
|
Topics |
- Angiotensin I
(pharmacology, therapeutic use)
- Animals
- Diabetes Mellitus, Experimental
(chemically induced, drug therapy, genetics, physiopathology)
- Glucose Transporter Type 2
(genetics, metabolism)
- Homeodomain Proteins
(genetics, metabolism)
- Insulin-Secreting Cells
(drug effects, metabolism)
- Islets of Langerhans
(drug effects, physiology)
- Male
- Peptide Fragments
(pharmacology, therapeutic use)
- Rats
- Rats, Wistar
- Streptozocin
- Trans-Activators
(genetics, metabolism)
- Up-Regulation
(drug effects, genetics)
|